ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

THE MEDICAL RESEARCH ON CARDIAC AUTONOMIC NEUROPATHY (CAN) IN DM CASES

AUTHORS:

Dr Mian Asif Mujtaba, Dr. Chaudhry Adeem Asim, Dr Ali Raza

ABSTRACT:

Background: Cardiovascular illnesses remain the most usual reason of illness also death in Dm cases. Cardiac autonomic neuropathy, the medically significant kind of DM autonomic neuropathy may remain very substantial reason of death in DM cases. Aims and Objectives: To investigate occurrence also danger aspects for cardiac autonomic neuropathy in Type 1 also Type 2 Diabetic Malicious and to investigate sympathy also specificity of modified QT intermission (QTc) in ECG in analysis of CAN in Diabetic Malicious. Materials and Methods: The current research is the cross-sectional research completed amongst cases joining DM surgery below Sir Ganga Ram Hospital Lahore, Pakistan from June 2018 to March 2019. Trials remained complete to appear for CAN also evaluate occurrence also danger aspects. The information remained gained afterwards well-versed agreement also investigated through EPI INFO. Results: The occurrence of Cardiac autonomic neuropathy amongst cases having Diabetic Malicious in the current research remained 74%. The suggestion of occurrence of Cardiac autonomic neuropathy by rise in period of Diabetic Malicious remained originate to stay statistically substantial. Conclusions: Cardiac autonomic neuropathy remains much known difficulty of together type 1 and type 2 Diabetic Malicious. Lengthier period of Diabetic Malicious also concurrent marginal neuropathy in addition continuation of QTc intermission in ECG stayed related by tall occurrence of Cardiac autonomic neuropathy in type 1 Diabetic Malicious. Developed age, lengthier period of Diabetic Malicious in addition concurrent peripheral neuropathy remain related by developed occurrence of CAN in type 2 Diabetic Malicious.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.